Summary
Reasonably high plasma levels were obtained 1/2 h after 8-methoxypsoralen (8-MOP) administration by microenema. This method was used in photochemotherapy of psoriasis and reasonably good clinical results with no serious side effects were obtained. The advantages of this modality include noninvolvement of the upper gastrointestinal tract, high bioavailability of psoralen, peak levels at a predictable time, and rapid elimination of the drug.
Similar content being viewed by others
References
Busch U, Schmid J, Koss FW, Zipp H, Zimmer A (1978) Pharmacokinetics and metabolite pattern of 8-methoxypsoralen in man following oral administration as compared to the pharmacokinetics in rat and dog. Arch Dermatol Res 262:255–265
Gazith J, Schalla W, Schaefer H (1978) 8-Methoxypsoralen-gas chromatographic determination and serum kinetics. Arch Dermatol Res 263:215–222
Glew WB, Roberts WP, Malinin GI, Nigra TP (1980) Quantitative determination by bioassay of photoactive 8-methoxypsoralen in serum. J Invest Dermatol 75:230–234
Kligman AM, Goldstein FP (1973) Oral dosage of methoxypsoralen phototoxicty. Arch Dermatol 107:548–550
Parrish JA, Fitzpatrick TB, Tannenbaum L, Pathak MA (1974) Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 291:1207–1211
Pathak MA, Dall'Acqua F, Rodighiero G, Parrish JA (1974) Metabolism of psoralens. J Invest Dermatol 62:347
Siddiqui AH, Cormane RH (1978) Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and long wave ultraviolet light (PUVA). Br J Dermatol 100:247–250
Steiner I, Prey T, Gschnait F, Washuttl J, Greiter F (1977) Serum level profiles of 8-methoxypsoralen after oral administration. Arch Dermatol Res 259:299–301
Stolk L (1980) Determination of 8-methoxypsoralen in body fluids by reverse phase H. P. L. C. Pharmac Weekblad (Sc. ed.) 2:29
Stolk L, Siddiqui AH, Kammeijer A, Cormane RH, van Zwieten PA (1981) Serum and saliva levels of 8-methoxypsoralen after rectal administration as micro-enema. Br J Dermatol 104:447–451
Stevenson IH, Kenicer KJA, Johnson BE, Frain-Bell W (1981) Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis. Br J Dermatol 104:47–51
Thune P (1978) Plasma of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinine tablets. Acta Derm Venereol (Stockh) 58:149–151
Thune P, Volden G (1977) Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation. Acta Derm Venereol (Stockh) 57:351–355
Wagner G, Hofmann C, Busch U, Schmid J, Plewig G (1979) 8-MOP plasma levels in PUVA problem cases with psoriasis. Br J Dermatol 101:285–292
Wolff K, Gschnait F, Honigsman H, Konrad K, Parrish JA, Fitzpatrick TB (1977) Phototesting and dosimetry for photochemotherapy. Br J Dermatol 96:1–10
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siddiqui, A.H., Stolk, L., Korthals Altes-Levij van Vinninghe, H.R. et al. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis. Arch Dermatol Res 273, 219–223 (1982). https://doi.org/10.1007/BF00409249
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00409249